7investing Lead Advisor Dana Abramovitz’s recommendation for September 2022 is a central component of the health care ecosystem, helping each player work together and more efficiently.
September 1, 2022
The health care industry is complicated, even for organizations that work as part of the ecosystem. New changes to regulations, as will be coming with the Inflation Reduction Act, make working in the industry even more challenging.
7investing Lead Advisor Dana Abramovitz’s recommendation for September 2022 is a central component of the complex health care ecosystem. It enables organizations to work together efficiently and through that to provide high quality, cost effective health care. It also has the relationships to educate and support companies as they transition to new regulations coming from the Inflation Reduction Act.
Navigating a new location, a new job, or even a new relationship can be challenging and we all can use a little help. This is also true for the health care industry, which is constantly navigating changes to the regulatory landscape.
Hi, I’m Dana Abramovitz, 7investing Lead Advisor. We’re here to empower you to invest in your future by giving you our 7 best stock recommendations every month.
My recommendation this month is a health care technology company that is central to the complex health care ecosystem and is well positioned to help members of the health care industry navigate changes to the system, from inflation to the Inflation Reduction Act. It has a stable business that it has developed over many decades and a new business that is seeing double digit growth and expects to reach those numbers over the next few years.
If you would like to learn more about all 7 recommendations this month, including mine, please visit 7investing.com/subscribe or click the link at the end of this video. We’re 7investing. We’re here to empower you to invest in your future.
Already a 7investing member? Log in here.